Antibiotice reported a net profit of RON31.14 million for 2014, slightly lower than RON31.38 million in the year before.
The company’s board proposed a gross dividend of RON0.02345 per share, 1.86% higher than the amount paid last year. Shareholders will vote on the proposal on April 30, when they will also vote of the 2015 budget.
For 2015, Antuibiotice estimates a 31.7% lower net profit, at RON21.26 million, while the sales revenue is seen 1.3% higher at RON323 million.